Select Medical acquired for $3.9B at $16.50/share, delisting from NYSE July 1, 2026

Select Medical Holdings Corporation has been acquired by a consortium led by its Executive Chairman Robert A. Ortenzio, Senior EVP Martin F. Jackson, and private equity firm WCAS for $16.50 per share, valuing the company at approximately $3.9 billion. This price represents an 18% premium over the unaffected share price before the acquisition proposal and a 25% premium over the 90-day average price. The acquisition was approved by shareholders and will become effective July 1, 2026, after which Select Medical's stock will cease trading and the company will be delisted from the NYSE. The consortium now holds majority control, with current leadership continuing in their roles.